Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionRecombinant human FMS-like tyrosine kinase 3 ligand (FLT3LG) that is a growth factor for dendritic cells and hematopoietic stem cells
Molecular Target FMS-like tyrosine kinase 3 ligand (FLT3LG)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard Indication Transplant (unspecified)
Indication DetailsMobilize hematopoietic stem cells in transplant patients
Regulatory Designation
PartnerCelldex Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today